3d Medicines (sichuan) Co., Ltd.

This study is testing an experimental immunotherapy drug called KN035 for people with advanced solid tumors that have specific genetic markers (dMMR or MSI-H). The trial is for patients whose cancer has continued to grow despite receiving standard treatments. Researchers want to …

This study is testing whether an immunotherapy drug called ENVAFOLIMAB can help control advanced solid tumors that have stopped responding to standard treatments. About 126 patients with various advanced cancers will receive the drug as a simple injection under the skin every fou…

This study is testing whether combining two drugs, Envafolimab and Lenvatinib, can help control advanced cancers like lung, kidney, and liver cancer that have progressed after standard treatments. The goal is to see if this combination is safe and can shrink tumors better than cu…

This study is testing two treatment approaches for advanced endometrial (uterine) cancer that has returned or spread after standard chemotherapy. It will compare an immunotherapy drug (envafolimab) given alone to the same drug combined with a targeted therapy (lenvatinib). The ma…

This study is for people with stage III non-small cell lung cancer that can be removed with surgery. It tests if adding a drug called envafolimab to standard chemotherapy, given both before and after surgery, works better and is safe compared to chemotherapy alone. The goal is to…